Encontrados 5 documentos, a visualizar página 1 de 1

Ordenado por Data

Downregulation of RKIP is associated with poor outcome and malignant progressio...

Martinho, Olga; Granja, Sara Costa; Jaraquemada, Teresa; Caeiro, Cláudia; Gonçalves, Vera M.; Honavar, Mrinalini; Costa, Paulo; Damasceno, Margarida

Malignant gliomas are highly infiltrative and invasive tumors, which precludes the few treatment options available. Therefore, there is an urgent need to elucidate the molecular mechanisms underlying gliomas aggressive phenotype and poor prognosis. The Raf Kinase Inhibitory protein (RKIP), besides regulating important intracellular signaling cascades, was described to be associated with progression, metastasis ...


Prognostic value of MGMT promoter methylation in glioblastoma patients treated ...

Costa, Bruno Marques; Caeiro, Cláudia; Guimarães, Inês; Martinho, Olga; Jaraquemada, Teresa; Augusto, Isabel; Castro, Lígia; Osório, Lígia

Glioblastoma (GBM) is the most common and aggressive primary brain tumor. The identification of novel molecular prognostic markers of GBM has recently been an area of great interest in neuro-oncology. The methylation status of the MGMT gene promoter is currently a promising molecular prognostic marker, but some controversial data have precluded its clinical use. We analyzed MGMT methylation by methylation-speci...


Biosimilars in oncology.

Barroso, Sérgio; Coutinho, Jorge; Damasceno, Margarida; Dinis, José; Forjaz de Lacerda, João; Gervásio, Helena; Leal da Costa, Fernando

The development of biotechnology drugs represents one of the great advances in medical therapy and it was observed an exponential growth in its use. The resource to these drugs in Oncology and Hematology is no exception and it soon became an essential element of an integrated and directed therapy strategy. The expiry of the first biotechnology drugs patents has opened the door for the development and marketing ...

Data: 2009   |   Origem: Acta Médica Portuguesa

Cost of cancer care in Portugal.

Araújo, António; Barata, Fernando; Barroso, Sérgio; Cortes, Paulo; Damasceno, Margarida; Parreira, António; Espírito Santo, Jorge; Teixeira, Encarnação

Cancer is the second most important cause of death in Portugal, following cardiovascular diseases (CVD), and shows a constant progressive increase in the proportional share of total deaths. In Portugal, as in most countries, the health care budget is under constant cost-containment pressures. In this context it is necessary to verify if enough resources have been allocated to the disease in terms of health care...

Data: 2009   |   Origem: Acta Médica Portuguesa

Guidelines for prevention of febrile neutropenia.

Barroso, Sérgio; Damasceno, Margarida; Dinis, José; Gervásio, Helena; da Luz, Ricardo; Passos-Coelho, J L; Sá, Anabela; Costa, Luís; Rodrigues, Helena

Neutropenia and febrile neutropenia are common consequences of some cytotoxic chemotherapy regimens. This situation leads to modifications of the therapeutic regimen, conducting to either dose reduction or cycle delays. Granulocyte colony stimulating factors are commonly used to minimize chemotherapy cytotoxic effect on the granulocytic series. The objective of this study is to assess the available evidence in ...

Data: 2008   |   Origem: Acta Médica Portuguesa

5 Resultados

Texto Pesquisado

Refinar resultados

Autor





















Data





Tipo de Documento


Tipo de acesso


Recurso



Assunto